Literature DB >> 15846498

Voiding and sexual dysfunction after deep rectal resection and total mesorectal excision: prospective study on 52 patients.

Peter Sterk1, Bijan Shekarriz, Svetlana Günter, Jan Nolde, Robert Keller, Hans-Peter Bruch, Hodjat Shekarriz.   

Abstract

OBJECTIVE: Voiding and sexual dysfunction after deep rectal resection have been described with various frequencies in the literature. In this study, we prospectively evaluated the baseline preoperative voiding and sexual function in a cohort of patients undergoing deep rectal resection with mesorectal excision to determine any pre-existing abnormalities. Postoperatively, we sought first to determine the frequency of a urinary or sexual dysfunction, secondly whether there is a time-dependent change of a dysfunction and thirdly whether there is a relationship between postoperative urological dysfunction and the patient's age. PATIENTS AND METHODS: Fifty-two patients (36 men and 16 women) with a primary rectal carcinoma were prospectively examined directly before and after the operation, as well after the third and sixth postoperative month. The preoperative urological evaluation consisted of a careful voiding and sexual history, uroflowmetry and a sonographic residual urine determination. A detailed sexual history was obtained via the use of a questionnaire.
RESULTS: Urological dysfunction: Preoperatively, 49 of the 52 patients had a completely normal bladder function and three patients had post void residual >100 ml. Postoperatively, 12 of the 49 patients with normal preoperatively urinary function had voiding dysfunction, but only four male patients had residual urine in the third postoperative month. Therefore, in about 90% of the patients, postoperative bladder function became normal and only 10% suffered from vesical denervation after 6 months. We could not determine a relationship between the degree of bladder dysfunction and the patient's age due to a relatively small patient cohort in this study. Sexual dysfunction: Preoperatively, 36 (seven women, 29 men) of the 52 patients were potent and had regular sexual intercourse. Eleven men specified a limited erection, but all had occasional sexual intercourse. One of the potent men experienced no ejaculation. Postoperatively, eight of the 29 men were impotent and two of the 29 men experienced retrograde ejaculation. Therefore, 30% of the preoperatively potent men had sexual dysfunction postoperatively. There was no correlation between the postoperative impotence and the age of the patients at the time of surgery. Although it is likely that the potency may diminish with advanced age, the incidence of impotence was not higher in the older patients of our study.
CONCLUSIONS: The results of our study underline the importance of risk estimation for possible postoperative urological dysfunction by means of preoperative urologic evaluation in this patient collective. Of patients with postoperative bladder dysfunction, 90% improved within 6 months after surgery and only 10% continued to have bladder dysfunction beyond 6 months, indicating irreversible nerve damage.

Entities:  

Mesh:

Year:  2005        PMID: 15846498     DOI: 10.1007/s00384-004-0711-4

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  14 in total

1.  Male sexual function after autonomic nerve-preserving operation for rectal cancer.

Authors:  H Masui; H Ike; S Yamaguchi; S Oki; H Shimada
Journal:  Dis Colon Rectum       Date:  1996-10       Impact factor: 4.585

2.  Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum.

Authors:  K Havenga; W E Enker; K McDermott; A M Cohen; B D Minsky; J Guillem
Journal:  J Am Coll Surg       Date:  1996-06       Impact factor: 6.113

3.  Radical and nerve-preserving surgery for rectal cancer in The Netherlands: a prospective study on morbidity and functional outcome.

Authors:  C P Maas; Y Moriya; W H Steup; G M Kiebert; W M Kranenbarg; C J van de Velde
Journal:  Br J Surg       Date:  1998-01       Impact factor: 6.939

4.  [The surgical anatomy of the genital nerves of the male and their preservation in excision of the rectum].

Authors:  F Stelzner; H Fritsch; K Fleischhauer
Journal:  Chirurg       Date:  1989-04       Impact factor: 0.955

5.  The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology.

Authors:  P Abrams; J G Blaivas; S L Stanton; J T Andersen
Journal:  Scand J Urol Nephrol Suppl       Date:  1988

6.  [Erection and ejaculation disorders following retroperitoneal lymphadenectomy in non-seminomatous testicular tumors].

Authors:  H Porst; J E Altwein; R Mayer; D Bach
Journal:  Urologe A       Date:  1984-11       Impact factor: 0.639

7.  Electrostimulation and penile erection.

Authors:  T F Lue; R A Schmidt; E A Tanagho
Journal:  Urol Int       Date:  1985       Impact factor: 2.089

Review 8.  Impotence after radical pelvic surgery: physiology and management.

Authors:  T F Lue
Journal:  Urol Int       Date:  1991       Impact factor: 2.089

9.  The quality of life after rectal excision for low rectal cancer.

Authors:  N S Williams; D Johnston
Journal:  Br J Surg       Date:  1983-08       Impact factor: 6.939

10.  Bladder and erectile dysfunction before and after rectal surgery for cancer.

Authors:  J Leveckis; N R Boucher; B T Parys; M W Reed; A J Shorthouse; J B Anderson
Journal:  Br J Urol       Date:  1995-12
View more
  28 in total

1.  Posterior sagittal approach for mesh rectopexy as a management of complete rectal in adults.

Authors:  Yehia Kosba; Walid Galal Elshazly; Walid Abd El Maksoud
Journal:  Int J Colorectal Dis       Date:  2010-04-01       Impact factor: 2.571

2.  Local treatment for rectal cancer.

Authors:  Daniel P Geisler
Journal:  Clin Colon Rectal Surg       Date:  2007-08

3.  Prediction of urinary retention after surgery for rectal cancer using voiding efficiency in the 24 h following Foley catheter removal.

Authors:  Ken Imaizumi; Yuichiro Tsukada; Yoshinobu Komai; Shogo Nomura; Koji Ikeda; Yuji Nishizawa; Takeshi Sasaki; Akinobu Taketomi; Masaaki Ito
Journal:  Int J Colorectal Dis       Date:  2019-07-06       Impact factor: 2.571

Review 4.  Sexual and urinary outcomes in robotic rectal surgery: review of the literature and technical considerations.

Authors:  Fabrizio Luca; Danielle K Craigg; Maheswari Senthil; Matthew J Selleck; Blake D Babcock; Mark E Reeves; Carlos A Garberoglio
Journal:  Updates Surg       Date:  2018-08-17

5.  Randomized controlled trial of tamsulosin for prevention of acute voiding difficulty after rectal cancer surgery.

Authors:  Je-Ho Jang; Sung-Bum Kang; Sung-Min Lee; Jun-Seok Park; Duck-Woo Kim; Soyeon Ahn
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

6.  Nerve-oriented mesorectal excision (NOME): autonomic nerves as landmarks for laparoscopic rectal resection.

Authors:  Norbert Runkel; Harald Reiser
Journal:  Int J Colorectal Dis       Date:  2013-05-11       Impact factor: 2.571

Review 7.  Urinary catheter management.

Authors:  Samantha Hendren
Journal:  Clin Colon Rectal Surg       Date:  2013-09

8.  A randomized pilot trial of a telephone-based couples intervention for physical intimacy and sexual concerns in colorectal cancer.

Authors:  Jennifer Barsky Reese; Laura S Porter; Katelyn R Regan; Francis J Keefe; Nilofer S Azad; Luis A Diaz; Joseph M Herman; Jennifer A Haythornthwaite
Journal:  Psychooncology       Date:  2014-02-26       Impact factor: 3.894

9.  Pilot feasibility study of a telephone-based couples intervention for physical intimacy and sexual concerns in colorectal cancer.

Authors:  Jennifer Barsky Reese; Laura S Porter; Tamara J Somers; Francis J Keefe
Journal:  J Sex Marital Ther       Date:  2012

10.  Male sexual function and lower urinary tract symptoms after laparoscopic total mesorectal excision.

Authors:  S O Breukink; M F van Driel; J P E N Pierie; C Dobbins; T Wiggers; W J H J Meijerink
Journal:  Int J Colorectal Dis       Date:  2008-08-15       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.